Combining methylated RNF180 and SFRP2 plasma biomarkers for noninvasive diagnosis of gastric cancer
Authors:
Open Access
- 13 November 2024
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 51, 102190
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient dataSupportive Care in Cancer, 2023
- Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancerCancer Communications, 2023
- Serum CA724 has no diagnostic value for gastrointestinal tumorsClinical and Experimental Medicine, 2023
- Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 studyCancer Immunology, Immunotherapy, 2023
- Self‐Healing Electronics for Prognostic Monitoring of Methylated Circulating Tumor DNAsAdvanced Materials, 2022
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAAnnals of Oncology, 2020
- Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancerBritish Journal of Surgery, 2016
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer AssociationGastric Cancer, 2013
- Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancerCancer, 2011
- Aberrant methylation of secreted frizzled‐related protein genes in esophageal adenocarcinoma and Barrett's esophagusInternational Journal of Cancer, 2005